RSV Seasonal Vaccine Introduction and Growth Strategy

Three key R&D priorities Uniting science, technology and talent to get ahead of disease together Science of the immune system and advanced technologies Execution Focus on pipeline acceleration and complementary business. development to deliver innovative vaccines and medicines Technology Using platform and data technology to deliver innovative vaccines and medicines Culture Building a culture that is ambitious for patients; attracting top talent and highly skilled specialists GSK

View entire presentation